We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

European Laboratory Information Systems Market

By Labmedica staff writers
Posted on 23 Nov 2006
The classic laboratory information system (LIS), designed as a multi-functional system to support hospital laboratory activities with emphasis on work and specimen flow for hospital inpatients and outpatients, has been dominant in clinical laboratories for more than three decades. This has led to 90-95% market penetration levels for LIS software.

According to Frost & Sullivan (Palo Alto, CA, USA), an international consulting firm, the European laboratory information systems market earned revenues of U.S.$153.7 million in 2005 and is estimated to reach U.S.$218.1 million in 2012.

Hospital laboratories are changing rapidly with greater emphasis on point-of-care and outreach testing, working in tandem with other automated systems in the hospital. Across Europe, almost half of the hospitals have a dedicated laboratory system. Vendors have therefore seen this as an opportunity to persuade hospitals of the benefits of an integrated hospital-wide system using the LIS as a selling tool.

"For many hospitals, the changes in LIS are related to a drive to connect together various hospital departments and departmental software,” explained Frost & Sullivan industry analyst Konstantinos Nikolopoulos. "Clinicians want to be able to enter data into electronic records and they want to both import and export data from electronic medical records [EMR] and hospital information systems [HIS] to LIS and vice-versa.”

Past trends have indicated that customers do not switch over to new vendors very easily, either due to financial considerations or simply to avoid the process of implementing new systems. "Market participants will need to show increased visibility in such a competitive environment,” advises Mr. Nikolopoulos. "Attendance and participation in trade shows and other industry-wide events can build company awareness, while the ability to highlight product capabilities and features in test/pilot sites can be an additional step in the same direction.”




Related Links:
Frost & Sullivan

New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Prefilled Tubes
Prefilled 5.0ml Tubes
New
Manual Pipetting Aid
Pipette Controllers macro

Latest Industry News

Integrated DNA Technologies Expands into Clinical Diagnostics
23 Nov 2006  |   Industry

Co-Diagnostics Agreement Expands Commercial and Distribution Reach in South Asia
23 Nov 2006  |   Industry

Automated MSI Test Gains IVDR Certification to Guide CRC Therapy
23 Nov 2006  |   Industry



INTEGRA BIOSCIENCES AG